In patients receiving nonselective monoamine oxidase inhibitors (MAOIs) (e.g., selegiline hydrochloride) in combination with serotoninergic agents (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline, venlafaxine), there have been reports of serious, sometimes fatal, reactions.
<monoamine oxidase inhibitors, effect, serotoninergic agents>, <monoamine oxidase inhibitors, effect, fluoxetine>, <monoamine oxidase inhibitors, effect, fluvoxamine>, <monoamine oxidase inhibitors, effect, paroxetine>, <monoamine oxidase inhibitors, effect, sertraline>, <monoamine oxidase inhibitors, effect, venlafaxine>, <MAOIs, effect, serotoninergic agents>, <MAOIs, effect, fluoxetine>, <MAOIs, effect, fluvoxamine>, <MAOIs, effect, paroxetine>, <MAOIs, effect, sertraline>, <MAOIs, effect, venlafaxine>, <selegiline hydrochloride, effect, serotoninergic agents>, <selegiline hydrochloride, effect, fluoxetine>, <selegiline hydrochloride, effect, fluvoxamine>, <selegiline hydrochloride, effect, paroxetine>, <selegiline hydrochloride, effect, sertraline>, <selegiline hydrochloride, effect, venlafaxine>